Structure

Physi-Chem Properties

Molecular Weight:  575.14
Volume:  543.593
LogP:  3.511
LogD:  1.469
LogS:  -4.096
# Rotatable Bonds:  2
TPSA:  190.36
# H-Bond Aceptor:  12
# H-Bond Donor:  6
# Rings:  7
# Heavy Atoms:  12

MedChem Properties

QED Drug-Likeness Score:  0.078
Synthetic Accessibility Score:  4.788
Fsp3:  0.267
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Rejected
Chelating Alert:  1
PAINS Alert:  1

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.839
MDCK Permeability:  7.735897270322312e-06
Pgp-inhibitor:  0.648
Pgp-substrate:  0.743
Human Intestinal Absorption (HIA):  0.929
20% Bioavailability (F20%):  0.025
30% Bioavailability (F30%):  0.377

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.009
Plasma Protein Binding (PPB):  82.14157104492188%
Volume Distribution (VD):  0.772
Pgp-substrate:  29.678138732910156%

ADMET: Metabolism

CYP1A2-inhibitor:  0.218
CYP1A2-substrate:  0.438
CYP2C19-inhibitor:  0.028
CYP2C19-substrate:  0.65
CYP2C9-inhibitor:  0.765
CYP2C9-substrate:  0.595
CYP2D6-inhibitor:  0.003
CYP2D6-substrate:  0.136
CYP3A4-inhibitor:  0.092
CYP3A4-substrate:  0.957

ADMET: Excretion

Clearance (CL):  2.629
Half-life (T1/2):  0.785

ADMET: Toxicity

hERG Blockers:  0.0
Human Hepatotoxicity (H-HT):  0.186
Drug-inuced Liver Injury (DILI):  0.979
AMES Toxicity:  0.417
Rat Oral Acute Toxicity:  0.015
Maximum Recommended Daily Dose:  0.765
Skin Sensitization:  0.155
Carcinogencity:  0.05
Eye Corrosion:  0.003
Eye Irritation:  0.006
Respiratory Toxicity:  0.068

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC315914

Natural Product ID:  NPC315914
Common Name*:   Citreamicin Epsilon
IUPAC Name:   n.a.
Synonyms:   Citreamicin Epsilon
Standard InCHIKey:  FJAZFAHKUIAABK-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C30H25NO11/c1-29(10-32)28(39)42-30(2)9-12-8-11-4-5-13-18(16(11)23(35)17(12)27(38)31(29)30)24(36)20-25(37)19-14(41-26(20)21(13)33)6-7-15(40-3)22(19)34/h6-8,32-36H,4-5,9-10H2,1-3H3
SMILES:  COc1ccc2c(c1O)c(=O)c1c(o2)c(O)c2c(c1O)c1c(CC2)cc2c(c1O)C(=O)N1C(C2)(C)OC(=O)C1(C)CO
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL507445
PubChem CID:   25147606
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0000123] Benzopyrans
        • [CHEMONTID:0003410] 1-benzopyrans
          • [CHEMONTID:0002817] Dibenzopyrans
            • [CHEMONTID:0000200] Xanthenes
              • [CHEMONTID:0000204] Xanthones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO19824 Streptomyces vinaceus Species Streptomycetaceae Bacteria n.a. n.a. n.a. PMID[19053507]
NPO19824 Streptomyces vinaceus Species Streptomycetaceae Bacteria n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT3190 Cell Line NHDF Homo sapiens CC90 = 0.1 ug ml-1 PMID[528814]
NPT16 Organism Staphylococcus aureus Staphylococcus aureus MIC = 0.13 ug.mL-1 PMID[528814]
NPT16 Organism Staphylococcus aureus Staphylococcus aureus MIC = 0.12 ug.mL-1 PMID[528814]
NPT16 Organism Staphylococcus aureus Staphylococcus aureus MIC = 0.25 ug.mL-1 PMID[528814]
NPT1531 Organism Enterococcus faecium Enterococcus faecium MIC = 0.5 ug.mL-1 PMID[528814]
NPT1118 Organism Streptococcus pneumoniae Streptococcus pneumoniae MIC = 0.25 ug.mL-1 PMID[528814]
NPT1118 Organism Streptococcus pneumoniae Streptococcus pneumoniae MIC = 0.12 ug.mL-1 PMID[528814]
NPT1122 Organism Haemophilus influenzae Haemophilus influenzae MIC > 32.0 ug.mL-1 PMID[528814]
NPT3189 Organism Haemophilus parainfluenzae Haemophilus parainfluenzae MIC > 32.0 ug.mL-1 PMID[528814]
NPT19 Organism Escherichia coli Escherichia coli MIC > 64.0 ug.mL-1 PMID[528814]
NPT19 Organism Escherichia coli Escherichia coli MIC > 32.0 ug.mL-1 PMID[528814]
NPT173 Organism Klebsiella pneumoniae Klebsiella pneumoniae MIC > 32.0 ug.mL-1 PMID[528814]
NPT1121 Organism Moraxella catarrhalis Moraxella catarrhalis MIC = 0.5 ug.mL-1 PMID[528814]
NPT1248 Organism Serratia marcescens Serratia marcescens MIC > 32.0 ug.mL-1 PMID[528814]
NPT18 Organism Pseudomonas aeruginosa Pseudomonas aeruginosa MIC > 32.0 ug.mL-1 PMID[528814]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. CC90 = 1.0 ug ml-1 PMID[528814]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC315914 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9429 High Similarity NPC316292
0.8287 Intermediate Similarity NPC82056
0.8133 Intermediate Similarity NPC185031
0.8111 Intermediate Similarity NPC38964
0.8044 Intermediate Similarity NPC211215
0.7952 Intermediate Similarity NPC83019
0.7905 Intermediate Similarity NPC204580
0.7887 Intermediate Similarity NPC286135
0.7883 Intermediate Similarity NPC170101
0.7864 Intermediate Similarity NPC478048
0.786 Intermediate Similarity NPC314946
0.7828 Intermediate Similarity NPC321226
0.7828 Intermediate Similarity NPC478046
0.7828 Intermediate Similarity NPC180210
0.7828 Intermediate Similarity NPC314914
0.7828 Intermediate Similarity NPC328856
0.7828 Intermediate Similarity NPC478047
0.7804 Intermediate Similarity NPC119818
0.7804 Intermediate Similarity NPC202771
0.7804 Intermediate Similarity NPC328700
0.7804 Intermediate Similarity NPC2173
0.7793 Intermediate Similarity NPC284236
0.7793 Intermediate Similarity NPC316368
0.7773 Intermediate Similarity NPC315253
0.7745 Intermediate Similarity NPC81332
0.7745 Intermediate Similarity NPC212038
0.7745 Intermediate Similarity NPC271848
0.7745 Intermediate Similarity NPC289396
0.7745 Intermediate Similarity NPC262580
0.774 Intermediate Similarity NPC150977
0.7729 Intermediate Similarity NPC324742
0.7729 Intermediate Similarity NPC473785
0.7714 Intermediate Similarity NPC105591
0.7703 Intermediate Similarity NPC208890
0.7696 Intermediate Similarity NPC80472
0.7689 Intermediate Similarity NPC131258
0.7681 Intermediate Similarity NPC207467
0.7674 Intermediate Similarity NPC316164
0.7671 Intermediate Similarity NPC46990
0.7659 Intermediate Similarity NPC4200
0.7659 Intermediate Similarity NPC158226
0.7653 Intermediate Similarity NPC24228
0.7644 Intermediate Similarity NPC185275
0.7635 Intermediate Similarity NPC272560
0.7633 Intermediate Similarity NPC324220
0.7633 Intermediate Similarity NPC216307
0.7633 Intermediate Similarity NPC312630
0.7619 Intermediate Similarity NPC469437
0.7617 Intermediate Similarity NPC124302
0.7617 Intermediate Similarity NPC70290
0.7617 Intermediate Similarity NPC73020
0.7617 Intermediate Similarity NPC14622
0.7617 Intermediate Similarity NPC215098
0.7617 Intermediate Similarity NPC46744
0.7611 Intermediate Similarity NPC44040
0.761 Intermediate Similarity NPC17219
0.7606 Intermediate Similarity NPC264302
0.7598 Intermediate Similarity NPC474024
0.7598 Intermediate Similarity NPC6588
0.7598 Intermediate Similarity NPC14662
0.7598 Intermediate Similarity NPC477154
0.7598 Intermediate Similarity NPC117854
0.7596 Intermediate Similarity NPC265380
0.7594 Intermediate Similarity NPC473618
0.7591 Intermediate Similarity NPC153365
0.7586 Intermediate Similarity NPC326520
0.7581 Intermediate Similarity NPC207239
0.7561 Intermediate Similarity NPC300307
0.7561 Intermediate Similarity NPC188079
0.7561 Intermediate Similarity NPC49487
0.7561 Intermediate Similarity NPC99613
0.7561 Intermediate Similarity NPC163130
0.7561 Intermediate Similarity NPC165979
0.756 Intermediate Similarity NPC113446
0.7559 Intermediate Similarity NPC295436
0.7549 Intermediate Similarity NPC37870
0.7549 Intermediate Similarity NPC472449
0.7549 Intermediate Similarity NPC472452
0.7549 Intermediate Similarity NPC170245
0.7548 Intermediate Similarity NPC196771
0.7547 Intermediate Similarity NPC179947
0.7547 Intermediate Similarity NPC174486
0.7546 Intermediate Similarity NPC226652
0.7546 Intermediate Similarity NPC120671
0.7546 Intermediate Similarity NPC314100
0.7546 Intermediate Similarity NPC72788
0.7545 Intermediate Similarity NPC257728
0.7537 Intermediate Similarity NPC236521
0.7537 Intermediate Similarity NPC152659
0.7537 Intermediate Similarity NPC474350
0.7537 Intermediate Similarity NPC197168
0.7537 Intermediate Similarity NPC248638
0.7537 Intermediate Similarity NPC270837
0.7537 Intermediate Similarity NPC7483
0.7537 Intermediate Similarity NPC236132
0.7536 Intermediate Similarity NPC154527
0.7536 Intermediate Similarity NPC310794
0.7536 Intermediate Similarity NPC327005
0.7535 Intermediate Similarity NPC314020
0.7535 Intermediate Similarity NPC477082
0.7524 Intermediate Similarity NPC102277
0.7524 Intermediate Similarity NPC124470
0.7524 Intermediate Similarity NPC53680
0.7524 Intermediate Similarity NPC208797
0.7524 Intermediate Similarity NPC313304
0.7524 Intermediate Similarity NPC279209
0.7524 Intermediate Similarity NPC265795
0.7524 Intermediate Similarity NPC109827
0.7524 Intermediate Similarity NPC47883
0.7523 Intermediate Similarity NPC477258
0.7512 Intermediate Similarity NPC477081
0.7512 Intermediate Similarity NPC243877
0.7512 Intermediate Similarity NPC472387
0.7512 Intermediate Similarity NPC476619
0.7512 Intermediate Similarity NPC234331
0.7512 Intermediate Similarity NPC247973
0.7512 Intermediate Similarity NPC476621
0.7512 Intermediate Similarity NPC477083
0.7512 Intermediate Similarity NPC476622
0.7512 Intermediate Similarity NPC297807
0.7512 Intermediate Similarity NPC476618
0.7512 Intermediate Similarity NPC205721
0.7512 Intermediate Similarity NPC476623
0.7512 Intermediate Similarity NPC476620
0.75 Intermediate Similarity NPC239752
0.75 Intermediate Similarity NPC472450
0.75 Intermediate Similarity NPC25361
0.75 Intermediate Similarity NPC314596
0.75 Intermediate Similarity NPC226725
0.75 Intermediate Similarity NPC261623
0.75 Intermediate Similarity NPC139350
0.75 Intermediate Similarity NPC471788
0.75 Intermediate Similarity NPC275780
0.75 Intermediate Similarity NPC469650
0.75 Intermediate Similarity NPC257266
0.75 Intermediate Similarity NPC227906
0.75 Intermediate Similarity NPC111490
0.749 Intermediate Similarity NPC133864
0.7488 Intermediate Similarity NPC174700
0.7488 Intermediate Similarity NPC260263
0.7488 Intermediate Similarity NPC25152
0.7488 Intermediate Similarity NPC257667
0.7488 Intermediate Similarity NPC162694
0.7488 Intermediate Similarity NPC186847
0.7488 Intermediate Similarity NPC294965
0.7488 Intermediate Similarity NPC472454
0.7488 Intermediate Similarity NPC121333
0.7477 Intermediate Similarity NPC160543
0.7477 Intermediate Similarity NPC174140
0.7477 Intermediate Similarity NPC472720
0.7477 Intermediate Similarity NPC93065
0.7477 Intermediate Similarity NPC472724
0.7477 Intermediate Similarity NPC469652
0.7477 Intermediate Similarity NPC472721
0.7477 Intermediate Similarity NPC31208
0.7476 Intermediate Similarity NPC475212
0.7476 Intermediate Similarity NPC153578
0.7476 Intermediate Similarity NPC299149
0.7476 Intermediate Similarity NPC114257
0.7476 Intermediate Similarity NPC183843
0.7476 Intermediate Similarity NPC212290
0.7476 Intermediate Similarity NPC84494
0.7476 Intermediate Similarity NPC245059
0.7476 Intermediate Similarity NPC476279
0.7476 Intermediate Similarity NPC244903
0.7476 Intermediate Similarity NPC277710
0.7475 Intermediate Similarity NPC228785
0.7475 Intermediate Similarity NPC14353
0.7475 Intermediate Similarity NPC56085
0.7465 Intermediate Similarity NPC475654
0.7465 Intermediate Similarity NPC226708
0.7464 Intermediate Similarity NPC49667
0.7464 Intermediate Similarity NPC8127
0.7464 Intermediate Similarity NPC473562
0.7463 Intermediate Similarity NPC39091
0.7463 Intermediate Similarity NPC224851
0.7463 Intermediate Similarity NPC20216
0.7463 Intermediate Similarity NPC277480
0.7463 Intermediate Similarity NPC30027
0.7463 Intermediate Similarity NPC29160
0.7463 Intermediate Similarity NPC43319
0.7463 Intermediate Similarity NPC128293
0.7453 Intermediate Similarity NPC49690
0.7453 Intermediate Similarity NPC22115
0.7453 Intermediate Similarity NPC275680
0.7453 Intermediate Similarity NPC231254
0.7452 Intermediate Similarity NPC261471
0.7451 Intermediate Similarity NPC220313
0.7451 Intermediate Similarity NPC475985
0.7451 Intermediate Similarity NPC67959
0.7451 Intermediate Similarity NPC189473
0.7451 Intermediate Similarity NPC146134
0.7451 Intermediate Similarity NPC23298
0.7451 Intermediate Similarity NPC207690
0.7451 Intermediate Similarity NPC273959
0.7441 Intermediate Similarity NPC470453
0.7441 Intermediate Similarity NPC470448
0.7441 Intermediate Similarity NPC470452
0.7441 Intermediate Similarity NPC18306
0.7441 Intermediate Similarity NPC477860

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC315914 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.7962 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7804 Intermediate Similarity NPD5005 Approved
0.7804 Intermediate Similarity NPD5006 Approved
0.7773 Intermediate Similarity NPD7667 Clinical (unspecified phase)
0.7689 Intermediate Similarity NPD8153 Approved
0.7689 Intermediate Similarity NPD8152 Approved
0.7639 Intermediate Similarity NPD7048 Phase 3
0.7626 Intermediate Similarity NPD7701 Phase 2
0.7617 Intermediate Similarity NPD4420 Approved
0.7611 Intermediate Similarity NPD8155 Clinical (unspecified phase)
0.7577 Intermediate Similarity NPD6997 Phase 2
0.7561 Intermediate Similarity NPD5844 Phase 1
0.7545 Intermediate Similarity NPD7585 Approved
0.7533 Intermediate Similarity NPD7907 Approved
0.7523 Intermediate Similarity NPD7783 Phase 2
0.7523 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD7584 Approved
0.75 Intermediate Similarity NPD7583 Approved
0.7488 Intermediate Similarity NPD6232 Discontinued
0.7463 Intermediate Similarity NPD7473 Discontinued
0.7445 Intermediate Similarity NPD4665 Approved
0.7445 Intermediate Similarity NPD4111 Phase 1
0.7432 Intermediate Similarity NPD8151 Discontinued
0.7431 Intermediate Similarity NPD3452 Approved
0.7431 Intermediate Similarity NPD2494 Approved
0.7431 Intermediate Similarity NPD3450 Approved
0.7431 Intermediate Similarity NPD2493 Approved
0.7416 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7415 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7415 Intermediate Similarity NPD6166 Phase 2
0.7415 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7391 Intermediate Similarity NPD5619 Clinical (unspecified phase)
0.7366 Intermediate Similarity NPD5242 Approved
0.7353 Intermediate Similarity NPD6959 Discontinued
0.7342 Intermediate Similarity NPD6973 Clinical (unspecified phase)
0.7339 Intermediate Similarity NPD8285 Discontinued
0.733 Intermediate Similarity NPD4583 Approved
0.733 Intermediate Similarity NPD4582 Approved
0.7317 Intermediate Similarity NPD5711 Approved
0.7317 Intermediate Similarity NPD5710 Approved
0.729 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7285 Intermediate Similarity NPD4004 Approved
0.7285 Intermediate Similarity NPD4002 Approved
0.7264 Intermediate Similarity NPD8053 Approved
0.7264 Intermediate Similarity NPD8054 Approved
0.726 Intermediate Similarity NPD7177 Discontinued
0.7252 Intermediate Similarity NPD8320 Phase 1
0.7252 Intermediate Similarity NPD8319 Approved
0.7248 Intermediate Similarity NPD2974 Approved
0.7248 Intermediate Similarity NPD2975 Approved
0.7248 Intermediate Similarity NPD2973 Approved
0.7227 Intermediate Similarity NPD6779 Approved
0.7227 Intermediate Similarity NPD6781 Approved
0.7227 Intermediate Similarity NPD6776 Approved
0.7227 Intermediate Similarity NPD6778 Approved
0.7227 Intermediate Similarity NPD6777 Approved
0.7227 Intermediate Similarity NPD6780 Approved
0.7227 Intermediate Similarity NPD6782 Approved
0.7222 Intermediate Similarity NPD8058 Clinical (unspecified phase)
0.7222 Intermediate Similarity NPD8059 Phase 3
0.722 Intermediate Similarity NPD5494 Approved
0.7217 Intermediate Similarity NPD2899 Discontinued
0.7207 Intermediate Similarity NPD7697 Approved
0.7207 Intermediate Similarity NPD7698 Approved
0.7207 Intermediate Similarity NPD7696 Phase 3
0.719 Intermediate Similarity NPD7074 Phase 3
0.7189 Intermediate Similarity NPD6212 Phase 3
0.7189 Intermediate Similarity NPD6214 Clinical (unspecified phase)
0.7189 Intermediate Similarity NPD6213 Phase 3
0.7182 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7176 Intermediate Similarity NPD3808 Clinical (unspecified phase)
0.7175 Intermediate Similarity NPD7871 Phase 2
0.7175 Intermediate Similarity NPD7870 Phase 2
0.717 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7168 Intermediate Similarity NPD7874 Approved
0.7168 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7162 Intermediate Similarity NPD7047 Phase 3
0.7157 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7156 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7149 Intermediate Similarity NPD4580 Approved
0.7143 Intermediate Similarity NPD7054 Approved
0.7143 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD2801 Approved
0.7137 Intermediate Similarity NPD5676 Approved
0.7109 Intermediate Similarity NPD7472 Approved
0.7097 Intermediate Similarity NPD2488 Approved
0.7097 Intermediate Similarity NPD2490 Approved
0.7095 Intermediate Similarity NPD3818 Discontinued
0.7094 Intermediate Similarity NPD1934 Approved
0.7064 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7062 Intermediate Similarity NPD6020 Phase 2
0.7059 Intermediate Similarity NPD1465 Phase 2
0.7059 Intermediate Similarity NPD8067 Phase 3
0.7056 Intermediate Similarity NPD8404 Phase 2
0.7054 Intermediate Similarity NPD4846 Phase 2
0.7054 Intermediate Similarity NPD7435 Discontinued
0.7046 Intermediate Similarity NPD7654 Discontinued
0.7045 Intermediate Similarity NPD4362 Clinical (unspecified phase)
0.7045 Intermediate Similarity NPD4361 Phase 2
0.7042 Intermediate Similarity NPD7039 Approved
0.7042 Intermediate Similarity NPD6559 Discontinued
0.7042 Intermediate Similarity NPD7038 Approved
0.7009 Intermediate Similarity NPD3448 Approved
0.7009 Intermediate Similarity NPD6823 Phase 2
0.7009 Intermediate Similarity NPD3057 Approved
0.7009 Intermediate Similarity NPD2491 Approved
0.7005 Intermediate Similarity NPD7906 Approved
0.7 Intermediate Similarity NPD4363 Phase 3
0.7 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD6625 Approved
0.7 Intermediate Similarity NPD6534 Approved
0.7 Intermediate Similarity NPD4360 Phase 2
0.7 Intermediate Similarity NPD6535 Approved
0.6995 Remote Similarity NPD6797 Phase 2
0.699 Remote Similarity NPD3882 Suspended
0.6987 Remote Similarity NPD7801 Approved
0.6982 Remote Similarity NPD7699 Phase 2
0.6982 Remote Similarity NPD7700 Phase 2
0.6981 Remote Similarity NPD8156 Discontinued
0.6978 Remote Similarity NPD7597 Clinical (unspecified phase)
0.6977 Remote Similarity NPD8313 Approved
0.6977 Remote Similarity NPD8312 Approved
0.6976 Remote Similarity NPD7819 Suspended
0.6963 Remote Similarity NPD7251 Discontinued
0.6951 Remote Similarity NPD7811 Phase 3
0.6951 Remote Similarity NPD7810 Phase 3
0.6944 Remote Similarity NPD7090 Clinical (unspecified phase)
0.6942 Remote Similarity NPD3817 Phase 2
0.6934 Remote Similarity NPD7228 Approved
0.6934 Remote Similarity NPD8252 Approved
0.6934 Remote Similarity NPD8099 Discontinued
0.6934 Remote Similarity NPD8251 Approved
0.6933 Remote Similarity NPD3533 Approved
0.6933 Remote Similarity NPD2972 Approved
0.693 Remote Similarity NPD7549 Discontinued
0.693 Remote Similarity NPD7808 Phase 3
0.692 Remote Similarity NPD4107 Approved
0.6916 Remote Similarity NPD7211 Clinical (unspecified phase)
0.6881 Remote Similarity NPD4663 Approved
0.6881 Remote Similarity NPD3863 Clinical (unspecified phase)
0.6881 Remote Similarity NPD8150 Discontinued
0.6878 Remote Similarity NPD7411 Suspended
0.6877 Remote Similarity NPD8461 Discontinued
0.6875 Remote Similarity NPD3749 Approved
0.6875 Remote Similarity NPD7075 Discontinued
0.6866 Remote Similarity NPD6851 Approved
0.6866 Remote Similarity NPD6853 Approved
0.686 Remote Similarity NPD7942 Clinical (unspecified phase)
0.6847 Remote Similarity NPD4413 Clinical (unspecified phase)
0.6832 Remote Similarity NPD2534 Approved
0.6832 Remote Similarity NPD2532 Approved
0.6832 Remote Similarity NPD2533 Approved
0.6829 Remote Similarity NPD4380 Phase 2
0.6828 Remote Similarity NPD7497 Discontinued
0.6824 Remote Similarity NPD7930 Approved
0.6822 Remote Similarity NPD3050 Clinical (unspecified phase)
0.6822 Remote Similarity NPD7804 Clinical (unspecified phase)
0.682 Remote Similarity NPD2971 Approved
0.682 Remote Similarity NPD2968 Approved
0.682 Remote Similarity NPD3534 Clinical (unspecified phase)
0.6814 Remote Similarity NPD4482 Phase 3
0.681 Remote Similarity NPD5677 Discontinued
0.681 Remote Similarity NPD7827 Phase 1
0.6802 Remote Similarity NPD6181 Discontinued
0.6798 Remote Similarity NPD4040 Phase 1
0.6791 Remote Similarity NPD5441 Clinical (unspecified phase)
0.6779 Remote Similarity NPD8443 Clinical (unspecified phase)
0.6777 Remote Similarity NPD7199 Phase 2
0.6774 Remote Similarity NPD8453 Clinical (unspecified phase)
0.6773 Remote Similarity NPD8367 Approved
0.6762 Remote Similarity NPD6234 Discontinued
0.6761 Remote Similarity NPD3451 Clinical (unspecified phase)
0.6759 Remote Similarity NPD6297 Approved
0.6758 Remote Similarity NPD8055 Clinical (unspecified phase)
0.6746 Remote Similarity NPD7768 Phase 2
0.6744 Remote Similarity NPD5313 Approved
0.6744 Remote Similarity NPD5312 Approved
0.6743 Remote Similarity NPD4577 Approved
0.6743 Remote Similarity NPD4578 Approved
0.6734 Remote Similarity NPD1483 Discontinued
0.6732 Remote Similarity NPD8492 Approved
0.6731 Remote Similarity NPD7096 Clinical (unspecified phase)
0.6722 Remote Similarity NPD8469 Approved
0.6721 Remote Similarity NPD7922 Phase 1
0.6714 Remote Similarity NPD4381 Clinical (unspecified phase)
0.6714 Remote Similarity NPD8005 Clinical (unspecified phase)
0.6712 Remote Similarity NPD5525 Clinical (unspecified phase)
0.6711 Remote Similarity NPD7238 Clinical (unspecified phase)
0.67 Remote Similarity NPD1511 Approved
0.6699 Remote Similarity NPD5353 Approved
0.6699 Remote Similarity NPD5402 Approved
0.6698 Remote Similarity NPD5940 Clinical (unspecified phase)
0.6698 Remote Similarity NPD7893 Clinical (unspecified phase)
0.6697 Remote Similarity NPD7291 Discontinued
0.6696 Remote Similarity NPD5457 Discontinued
0.6696 Remote Similarity NPD8161 Suspended
0.6683 Remote Similarity NPD6801 Discontinued
0.6683 Remote Similarity NPD37 Approved
0.6681 Remote Similarity NPD7064 Clinical (unspecified phase)
0.668 Remote Similarity NPD7223 Discontinued

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data